Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion

Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion

April 29, 2013
Approaching Biopharma Catalyst Events

Approaching Biopharma Catalyst Events

April 24, 2013
Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks.

Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks.

April 23, 2013
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential

AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential

April 16, 2013
I bought $BDSI.. Chart with basic DD

I bought $BDSI.. Chart with basic DD

April 2, 2013
Updated: (cleaned up) Market Historical Chart For Review: Economic Commentary and Market Forecast Opinion.

Updated: (cleaned up) Market Historical Chart For Review: Economic Commentary and Market Forecast Opinion.

April 1, 2013
← →
  • Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion
  • Approaching Biopharma Catalyst Events
  • Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks.
  • AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential
  • I bought $BDSI.. Chart with basic DD
  • Updated: (cleaned up) Market Historical Chart For Review: Economic Commentary and Market Forecast Opinion.

Recent Articles

Deeper BDSI Chart and Indicators

Deeper BDSI Chart and Indicators

May 24, 2013
by

As you can see from the daily 100-day chart above, BDSI is setting up for a continuation move off the reversal bounce from support.  Yesterday,…

Read Article →
I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

May 23, 2013
by

BioDelivery Sciences (BDSI) focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible…

Read Article →
I bought Antares @ $3.95, I see a move to $4.35 short term

I bought Antares @ $3.95, I see a move to $4.35 short term

May 15, 2013
by

I bought Antares @ $3.95, I see a move to $4.35 short term. I think from tomorrow to beginning of next week, we see the…

Read Article →

More Articles

Insmed Chart technicals with my opinion and explanation: YouTube Video

May 14, 2013 / by / in

Weekend Biotech Update: $AVEO $AGEN

April 28, 2013 / by / in

Agenus Roth Capital Analyst Report

April 26, 2013 / by / in

Weekend update with some charts, Market forecast and opinion. (VIDEO)

April 22, 2013 / by / in

AVEO Pharma’s Tivozanib Likely To Be Approved

March 28, 2013 / by / in

Antares Pharma ($ATRS) Technical Long Trade Thesis and Chart

March 22, 2013 / by / in

Aveo Chart Technicals

March 21, 2013 / by / in

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals.

March 17, 2013 / by / in

AcelRx Pharma Selloff Caused By Error In Recent Press Release

March 15, 2013 / by / in

Why the latest rally could be a bull trap

February 28, 2013 / by / in

GLOBE NEWSWIRE: Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia

February 21, 2013 / by / in

4 Small Cap Biopharmas With Near-Term Catalysts

February 11, 2013 / by / in
s2Member®